Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

US Pharmaceuticals Ishares ETF (IHE)

US Pharmaceuticals Ishares ETF (IHE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Will J&J ETFs Suffer on Latest COVID-19 Vaccine Updates?

Let's take a look at some ETFs that can see adverse impacts as Johnson & Johnson's coronavirus vaccine sees a setback amid the worsening pandemic conditions.

JNJ : 160.39 (+0.29%)
XLV : 120.58 (+1.71%)
IYH : 261.65 (+1.83%)
IHE : 177.80 (+0.96%)
FTXH : 25.83 (+0.31%)
IEIH : 32.81 (+1.16%)
ETFs to Shine on Pfizer's Impressive COVID-19 Vaccine Update

Here we highlight some ETFs with high exposure to Pfizer (PFE) that can gain from the encouraging progress in coronavirus vaccine development as the outbreak worsens.

PFE : 37.60 (+1.16%)
MRNA : 159.87 (-0.10%)
IHE : 177.80 (+0.96%)
FDL : 33.33 (+0.21%)
FTXH : 25.83 (+0.31%)
IEIH : 32.81 (+1.16%)
BNTX : 140.72 (+6.12%)
J&J ETFs to Shine Bright as FDA Grants EUA for Coronavirus Vaccine

Johnson & Johnson's receipt of EUA for its single-shot COVID-19 vaccine will strengthen the U.S. government's position in the fight against the pandemic and benefit ETFs with high exposure to the pharmaceutical...

JNJ : 160.39 (+0.29%)
XLV : 120.58 (+1.71%)
IYH : 261.65 (+1.83%)
IHE : 177.80 (+0.96%)
FTXH : 25.83 (+0.31%)
IEIH : 32.81 (+1.16%)
How to Trade USFDA's EUA to J&J Vaccine With ETFs

On Feb 27, the United States sanctioned Johnson & Johnson's COVID-19 vaccine for emergency use, giving the nation a third vaccine to fight the outbreak, after BioNTech/Pfizer and Moderna.

JNJ : 160.39 (+0.29%)
XLV : 120.58 (+1.71%)
JETS : 26.58 (-0.93%)
MNA : 33.24 (+0.57%)
IHE : 177.80 (+0.96%)
VOE : 138.30 (+0.35%)
IAT : 57.27 (-1.17%)
Pharma ETFs in Focus Post Q4 Earnings

Healthcare Q4 results seem robust given that it is the fourth-best sector from a revenue growth look and the sixth-strongest in terms of earnings growth.

JNJ : 160.39 (+0.29%)
PFE : 37.60 (+1.16%)
MRK : 76.66 (+0.34%)
LLY : 185.92 (+1.60%)
BMY : 64.44 (+0.99%)
PPH : 68.97 (+1.10%)
PJP : 79.45 (+0.84%)
IHE : 177.80 (+0.96%)
XPH : 48.98 (-0.10%)
FTXH : 25.83 (+0.31%)
JNJ Touches New Highs Post Solid Q4 Earnings: ETFs in Focus

The solid results coupled with upbeat vaccine data optimism pushed JNJ shares to all-time high.

JNJ : 160.39 (+0.29%)
PFE : 37.60 (+1.16%)
MRNA : 159.87 (-0.10%)
XLV : 120.58 (+1.71%)
VHT : 236.72 (+1.85%)
IYH : 261.65 (+1.83%)
IHE : 177.80 (+0.96%)
IEIH : 32.81 (+1.16%)
Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?

Sector ETF report for PPH

PPH : 68.97 (+1.10%)
NVO : 71.51 (+1.36%)
AZN : 50.83 (+1.99%)
BMY : 64.44 (+0.99%)
PJP : 79.45 (+0.84%)
IHE : 177.80 (+0.96%)
ETFs to Shine on Lilly's Coronavirus Antibody Progress

Eli Lilly's (LLY) progress in antibodies treatment is expected to raise investors' optimism.

PPH : 68.97 (+1.10%)
PJP : 79.45 (+0.84%)
IHE : 177.80 (+0.96%)
XPH : 48.98 (-0.10%)
Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?

Sector ETF report for PPH

PPH : 68.97 (+1.10%)
NVO : 71.51 (+1.36%)
AZN : 50.83 (+1.99%)
BMY : 64.44 (+0.99%)
PJP : 79.45 (+0.84%)
IHE : 177.80 (+0.96%)
Should You Invest in the SPDR SP Pharmaceuticals ETF (XPH)?

Sector ETF report for XPH

XPH : 48.98 (-0.10%)
RPRX : 41.65 (-1.12%)
HZNP : 93.51 (+2.25%)
PJP : 79.45 (+0.84%)
IHE : 177.80 (+0.96%)
MYOK : 224.91 (+0.05%)
Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?

Sector ETF report for PPH

PPH : 68.97 (+1.10%)
NVO : 71.51 (+1.36%)
AZN : 50.83 (+1.99%)
BMY : 64.44 (+0.99%)
PJP : 79.45 (+0.84%)
IHE : 177.80 (+0.96%)
Q3 Earnings Fail to Impress Pharma ETFs

The slew of Q3 results have led to mixed trading in pharma ETFs over the past month.

PPH : 68.97 (+1.10%)
PJP : 79.45 (+0.84%)
IHE : 177.80 (+0.96%)
XPH : 48.98 (-0.10%)
FTXH : 25.83 (+0.31%)
ETFs to Shine on Lilly's U.S. Deal for Coronavirus Antibody

Eli Lilly's (LLY) progress in antibodies treatment is expected to raise investors' optimism.

PPH : 68.97 (+1.10%)
PJP : 79.45 (+0.84%)
IHE : 177.80 (+0.96%)
XPH : 48.98 (-0.10%)
Healthcare ETFs: Winners & Losers in the Light of U.S. Election

The coronavirus vaccine development effort has put the spotlight on the U.S. healthcare sector in recent months.

IHI : 351.82 (+2.25%)
IHF : 260.03 (+2.21%)
PJP : 79.45 (+0.84%)
IHE : 177.80 (+0.96%)
XHE : 123.81 (+1.27%)
GNOM : 22.86 (+1.37%)
CNBS : 26.61 (-2.06%)
Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?

Sector ETF report for PPH

PPH : 68.97 (+1.10%)
NVO : 71.51 (+1.36%)
AZN : 50.83 (+1.99%)
BMY : 64.44 (+0.99%)
PJP : 79.45 (+0.84%)
IHE : 177.80 (+0.96%)
J&J Pauses Coronavirus Vaccine Trial: ETFs That May Take a Hit

Johnson & Johnson's pausing of dosing in all clinical studies on its coronavirus vaccine candidate has increased uncertainty surrounding the coronavirus vaccine development.

XLV : 120.58 (+1.71%)
VHT : 236.72 (+1.85%)
IYH : 261.65 (+1.83%)
IHE : 177.80 (+0.96%)
IEIH : 32.81 (+1.16%)
JNJ Beats Q3 Earnings, Lifts Outlook: Healthcare ETFs in Focus

Despite solid results and an upbeat view, shares of JNJ dropped as the company halted its final-phase of clinical trials for its COVID-19 vaccine candidate.

JNJ : 160.39 (+0.29%)
XLV : 120.58 (+1.71%)
VHT : 236.72 (+1.85%)
IYH : 261.65 (+1.83%)
IHE : 177.80 (+0.96%)
IEIH : 32.81 (+1.16%)
Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?

Sector ETF report for PPH

PPH : 68.97 (+1.10%)
JNJ : 160.39 (+0.29%)
AZN : 50.83 (+1.99%)
PFE : 37.60 (+1.16%)
PJP : 79.45 (+0.84%)
IHE : 177.80 (+0.96%)
Pharma ETFs to Benefit from Lilly's Coronavirus Antibody Progress

Lilly's progress in antibodies treatment is expected to raise investors optimism.

PPH : 68.97 (+1.10%)
PJP : 79.45 (+0.84%)
IHE : 177.80 (+0.96%)
XPH : 48.98 (-0.10%)
Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?

Sector ETF report for PPH

PPH : 68.97 (+1.10%)
AZN : 50.83 (+1.99%)
PFE : 37.60 (+1.16%)
LLY : 185.92 (+1.60%)
PJP : 79.45 (+0.84%)
IHE : 177.80 (+0.96%)

Barchart Exclusives

The Wheat Bull Remains Intact At The Start Of The 2021 Crop Year
CBOT wheat futures are heading into the new crop year at the highest price in years. As the demand side of wheat’s fundamental equation is ever-increasing, consumers worldwide hope that 2021 is another year of bumper crops. Any supply issues could launch the wheat price even higher over the coming months. Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar